Boston, MA 08/15/2014 (wallstreetpr) – The acquisition between Medtronic, Inc. (NYSE:MDT) and Covidien plc (NYSE:COV) has generated a lot more attraction of the market participants. It especially becomes all more significant as Medtronic has adopted Ireland as its headquarters. It is more about the corporate inversions that allow businesses to come and invest more in the U.S. Calling Ireland as its legal headquarters means that Medtronic can bring $1 billion or even more in the United States without facing any penalty.
The significance
Medtronic, Inc. (NYSE:MDT) has got better cash book as compared to Covidien. In fact, it has got an impressive cash picture of its foreign subsidiaries. It holds around $13 billion in cash in the foreign subsidiaries. However, the cash is open for the extra taxation as and when it crosses the U.S. border. This is not the case with Covidien who can bring the money back in the U.S. and can invest it without facing any penalty. The concept will be applicable on the all of Covidien’s cash flow in the coming time.
The tax picture
There is no hidden story about the prevailing income tax rate structure in the US. It has got the highest corporate income tax rate among the developed regions. Therefore, the corporate companies seek to invest outside the United States. However, the companies have started to opt for inversions. In it, a U.S. company acquires a foreign company and gets the legal official address of the foreign company. The operational headquarters stays in the U.S.
The benefits
The U.S. companies find it tough to deal with the profits that return from a foreign country into the US. They have to pay IRS on the profits. And coming to Medtronic, Inc. (NYSE:MDT), it has to pay additional taxes amounting in billions in the case it wants to bring the profit from the foreign land to its home country. And, therefore, it intends to benefit from the Covidien so that there will be no problems in making investments in the U.S.
